About this trial
The purpose of this study is to demonstrate the efficacy of early continuous intravenous infusion of hypertonic saline solution (HSS) to improve survival and independence in daily life activities (at 6 months) of patients with traumatic brain injury at high risk of intracranial hypertension.
Eligibility criteria
Qualifiers
Patient admitted to intensive care unit
Traumatic brain injury with Glasgow Coma Scale ≤ 12
Intracranial pressure (ICP) monitoring based on the attending physician's clinical judgment, in accordance with guidelines or clinical/radiological signs considered at risk of intracranial hypertension
Inclusion during the first 12 hours after Intracranial pressure monitoring placement
Disqualifiers
Glasgow Coma Scale (score = 3) and persistent abnormal pupillaryreactivity despite urgent therapy
Associated cervical spinal cord injury
Imminent death and do-not-resuscitate orders
Coma secondary to cardiac arrest
Trial design
Treatments tested in this trial
- Hypertonic saline solution